- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 5/0781 - B cells; Progenitors thereof
Patent holdings for IPC class C12N 5/0781
Total number of patents in this class: 672
10-year publication summary
34
|
39
|
65
|
77
|
56
|
58
|
69
|
54
|
54
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immusoft Corporation | 22 |
15 |
Hoffmann-La Roche Inc. | 3267 |
14 |
Duke University | 3011 |
14 |
Dana-Farber Cancer Institute, Inc. | 2535 |
13 |
F. Hoffmann-La Roche AG | 7942 |
12 |
The Invention Science Fund II, LLC | 91 |
11 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
11 |
The Board of Trustees of the Leland Stanford Junior University | 6246 |
10 |
Crystal Bioscience Inc. | 83 |
10 |
The Regents of the University of California | 19517 |
9 |
Centre National de La Recherche Scientifique | 10102 |
8 |
President and Fellows of Harvard College | 5913 |
8 |
Kaneka Corporation | 4498 |
8 |
Sanofi Pasteur VaxDesign Corporation | 47 |
8 |
Iovance Biotherapeutics, Inc. | 317 |
8 |
Kling Biotherapeutics B.V. | 31 |
8 |
Institute for Research in Biomedicine | 98 |
7 |
Sdf Biopharma Inc. | 10 |
7 |
The Johns Hopkins University | 5533 |
6 |
Ohio State Innovation Foundation | 1978 |
6 |
Other owners | 479 |